BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36082758)

  • 1. Extracorporeal photopheresis: A case of graft-versus-host-disease and hemophagocytic lymphohistiocytosis following liver transplantation.
    Xu Z; Otrock ZK
    Transfusion; 2022 Nov; 62(11):2409-2413. PubMed ID: 36082758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
    Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
    J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis in solid organ transplant-associated acute graft-versus-host disease.
    Houston BL; Yan M; Tinckam K; Kamel-Reid S; Chang H; Kuo KH; Tsien C; Seftel MD; Avitzur Y; Grant D; Cserti-Gazdewich CM
    Transfusion; 2016 Apr; 56(4):962-9. PubMed ID: 26892365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.
    Kitko CL; Braun T; Couriel DR; Choi SW; Connelly J; Hoffmann S; Goldstein S; Magenau J; Pawarode A; Reddy P; Schuler C; Yanik GA; Ferrara JL; Levine JE
    Biol Blood Marrow Transplant; 2016 May; 22(5):862-8. PubMed ID: 26551636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photopheresis for the treatment of chronic graft versus host disease.
    Kansu E; Ward D; Sanchez AP; Cunard R; Hayran M; Huseyin B; Vaughan M; Ku G; Curtin P; Mulroney C; Costello C; Castro JE; Wieduwilt M; Corringham S; Ihasz-Davis A; Nelson C; Ball ED
    Hematology; 2022 Dec; 27(1):785-794. PubMed ID: 35802815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
    Child FJ; Ratnavel R; Watkins P; Samson D; Apperley J; Ball J; Taylor P; Russell-Jones R
    Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of graft versus host disease (GVHD) by photopheresis?
    Schooneman F; Claise C
    Transfus Sci; 1996 Dec; 17(4):527-36. PubMed ID: 10168550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
    Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2018; 9():2207. PubMed ID: 30349527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophagocytic Lymphohistiocytosis in Renal Transplant Recipients: A 2-Case Report.
    Mascia G; Argiolas D; Carta E; Ibba S; Piredda GB
    Transplant Proc; 2020 Jun; 52(5):1566-1569. PubMed ID: 32389490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Bassler D
    Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
    Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
    Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse model.
    Budde H; Kolb S; Salinas Tejedor L; Wulf G; Reichardt HM; Riggert J; Legler TJ
    PLoS One; 2014; 9(8):e105896. PubMed ID: 25148404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
    Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
    Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
    Budde H; Papert S; Reichardt HM; Jarry H; Riggert J; Legler TJ
    Vox Sang; 2018 Nov; 113(8):803-810. PubMed ID: 30353554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of extracorporeal photopheresis in pediatric patients with graft-versus-host disease after hematopoietic stem cell transplantation.
    Winther-Jørgensen S; Nygaard M; Heilmann C; Ifversen M; Sørensen K; Müller K; Masmas T
    Pediatr Transplant; 2019 Jun; 23(4):e13416. PubMed ID: 30973668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilization.
    Yerrabothala S; Talebian L; Klinker K; Hickman J; Hill JM; Hayes C; Lowrey C; Szczepiorkowski ZM; Meehan KR
    J Clin Apher; 2018 Jun; 33(3):310-315. PubMed ID: 29193271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
    Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Outcomes of Extracorporeal Photopheresis With the Therakos Cellex System for Graft-Versus-Host Disease in Pediatric Patients.
    Uygun V; Daloglu H; Karasu G; Hazar V; Yeşilipek A
    J Pediatr Hematol Oncol; 2015 Apr; 37(3):209-14. PubMed ID: 25374287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host disease.
    Cid J; Carbassé G; Suárez-Lledó M; Moreno DF; Martínez C; Gutiérrez-García G; Fernández-Avilés F; Rosiñol L; Giavedoni P; Mascaró JM; Agustí C; Marín P; Rovira M; Urbano-Ispizua Á; Lozano M
    Transfusion; 2019 Aug; 59(8):2636-2642. PubMed ID: 31135994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid organ graft-versus-host disease in a recipient of a COVID-19 positive liver graft.
    Ashcherkin N; Pisipati S; Athale J; Carey EJ; Chascsa D; Adamski J; Shah S
    J Liver Transpl; 2023 May; 10():100154. PubMed ID: 38013675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.